Aishwarya Ramachandran, MD
Endocrinology, Diabetes & Metabolism Physician · Sugar Land, TX
Aishwarya Ramachandran, MD is an endocrinology, diabetes & metabolism physician with a practice address in Sugar Land, Texas, and NPI 1407209448, issued on Jul 14, 2016. Check the license (Texas U2987, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Aishwarya Ramachandran
- Credential
- MD
- Primary taxonomy
- Endocrinology, Diabetes & Metabolism Physician 207RE0101X
- License number
- U2987 TX
Self-reported in NPPES; status is on the state search - Practice location
- 11555 University Blvd, Sugar Land, TX 77478
- Phone
- (713) 442-9100
- Enumerated
- Jul 14, 2016
- Record last updated
- Mar 12, 2024
- Medicare enrollment
- Enrolled (PECOS I20230913004379); accepts Medicare assignment
- Entity
- Type 1 · individual
8 nearest endocrinology, diabetes & metabolism physician records → All 743 in Texas → Look up another NPI →
Also registered at 11555 University Blvd
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Yetunde Adigun, MDObstetrics & Gynecology Physician1730356569
- Kamran Ahmed, MDHospitalist Physician1952562126
- Maria Argao, MDFamily Medicine Physician1629003769
- Cecilio Batres, MDDermatology Physician1760412423
- Spencer Berthelsen, MDInternal Medicine Physician1295763290
- Melinda Chai, MDObstetrics & Gynecology Physician1336778075
Verify Aishwarya Ramachandran in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license U2987Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
69% fewer Medicare Part D claims than the average endocrinology, diabetes & metabolism physician in 2024
818 Medicare Part D claims for 173 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 49% of claims.
Most prescribed
- Levothyroxine Sodium92 claims
- Mounjaro82 claims
- Ozempic82 claims
- Rosuvastatin Calcium46 claims
- Glimepiride34 claims
- Trulicity33 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Bills Medicare through one group practice
- Kelsey-Seybold Medical Group, PLLCSugar Land, TX
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Aishwarya Ramachandran among 743 endocrinology, diabetes & metabolism physician records in Texas
Aishwarya Ramachandran, MD is one of 743 endocrinology, diabetes & metabolism physician records with a practice address in Texas. 87% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2016, is newer than 84% of them.
- NPI issued2016 · 84% of these records are older, 13% newer
- In a Medicare fileYes · 87% of these records are
- In the CMS Doctors and Clinicians fileYes · 75% of these records are
- Graduated2014 · median 2004 among the 560 with a school on file
- Record last updated2024 · 50% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RE0101X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Endocrinology, Diabetes & Metabolism Physician providers in Texas
There are 743 endocrinology, diabetes & metabolism physician records in Texas.
All 743 in Texas → Every provider in Sugar Land → Endocrinology, Diabetes & Metabolism Physician nationwide →
The 8 endocrinology, diabetes & metabolism physician records with the nearest ZIP codes
- Jalaja Joseph, MDSugar Land, TX 774781922388057
- Swarna Kamble, MDSugar Land, TX 774781528194370
- Shelly Mathur, M.D.Sugar Land, TX 774781831344530
- Masha Resman, M.D.Sugar Land, TX 774781013143890
- Elias Stephan, MDSugar Land, TX 774781811981996
- Amelita Lourdes Basa, M.D.Sugar Land, TX 774791598786691
- Chhavi Chadha, M.DSugar Land, TX 774791952593451
- Daniel Corredor, MDStafford, TX 774771003906512
Common questions
What is Aishwarya Ramachandran, MD's NPI number?
Aishwarya Ramachandran, MD's National Provider Identifier (NPI) is 1407209448, issued on Jul 14, 2016. An NPI identifies a provider in billing; it is not a license.
Where is Aishwarya Ramachandran, MD located?
The NPPES record lists a practice address at 11555 University Blvd, Sugar Land, TX, 77478. Phone: (713) 442-9100. Providers update this record themselves, so call before visiting.
How can I verify Aishwarya Ramachandran, MD's license?
NPPES lists Texas license number U2987, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Aishwarya Ramachandran, MD prescribe under Medicare Part D?
In 2024, Aishwarya Ramachandran, MD had 818 Medicare Part D claims for 173 beneficiaries; the average among endocrinology, diabetes & metabolism physician prescribers was 2,630. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.